In this cohort, men with PCa receiving GnRH agonists had a decreased risk of elevated blood pressure compared with men with PCa not receiving GnRH agonists (HR, 0.68; 95% CI, 0.56-0.82) (Table 3 and Figure 2F-J; eTable 1 and eTable 2 in the Supplement). Here, GNRH1 is linked to posterior cortical atrophy.